MURRAY RICHARD /CA/ (CEO and President) received a stock award from JOUNCE THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/3/2022ACC: 0001640455-22-000017
DirectorOfficer· CEO and President
Since Sep 2018
+262.50K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
262.50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+87.50K
Price / share
—
Trade value
—
% of position
47.2%
2/1/2022
185.58K→273.08K
Total
Net shares
+87.50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/1/2022 | A · Award | +87.50K | — | — | 47.2% | 185.58K | 273.08K |
| Total | +87.50K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
175K shares
Shares
+175K
Strike price
7.56
Held after
175K
Exercisable
—
2/1/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock175K shares | 2/1/2022 | A · Award | +175K | 7.56 | — | 175K |